Association between maternal tumor necrosis factor-alpha G308A polymorphism and interferon-gamma A874T polymorphism and risk of preterm birth: a meta-analysis

作者:Liu Ying; Yao Ci Jiang; Tao Fang Biao; Luo Chun Miao; Cao Yi; Zhao Su Juan; Chen Yan Yan; Zhu Xiao Xia; Cao Ji Yu*
来源:European Journal of Obstetrics & Gynecology and Reproductive Biology, 2015, 190: 11-19.
DOI:10.1016/j.ejogrb.2015.04.003

摘要

Objective(s): This article was undertaken to investigate the association between tumor necrosis factor-alpha (TNF-alpha) G308A polymorphism and interferon-gamma (INF-gamma) A874T polymorphism and risk of preterm birth (PTB) by performing a meta-analysis of available studies. Study design: Articles were chosen based on PubMed, EMBASE, Web of science, and China Biology Medicine (CBM) databases with no language restriction from their inceptions to 1 March, 2014. Specific inclusion criteria were used to evaluate articles. Meta-analysis was performed by using a random or fixed effect model with STATA 11.0 software. We estimated the summary odds ratios (ORs) with its corresponding 95% confidence interval (95%CI) to assess the association. Results: 21 eligible case-control studies with a total of 2103 cases and 5070 controls were finally included into this meta-analysis. Pooled analysis showed that A allele of TNF-alpha G308A was not associated with increased PTB risk (OR = 0.84, 95%CI: 0.65-1.07,p = 0.167 for G vs. A). Stratifying analysis for ethnicity and different definition of PTB also indicated that A allele was not associated with increased PTB risk. However, the meta-analysis showed that INF-gamma A874T polymorphism was associated with the increased risk of PTB (OR = 1.14, 95%CI: 1.11-1.73, p = 0.004 for A vs. T). Stratifying analysis was not performed due to the small sample size. Conclusion(s): TNF-alpha. G308A polymorphism was not associated with an increased risk of PTB, but INF-gamma A874T polymorphism may contribute to increasing susceptibility to PTB. Detection of polymorphism of INF-gamma A874T might be a promising biomarker for the diagnosis and prognosis of preterm delivery.